Diagnostics and treatment of ADHD in Switzerland: A physician perspective on practice and challenges

Abstract

Background:Attention deficit/hyperactivity disorder (ADHD) is a major public health problem with numerous negative outcomes for the affected individuals and with a high burden to families and society. Although a multimodal therapeutic approach (i.e., pharmacological treatment as well as non-pharmaceutical treatment options) is considered the gold standard, the observed increasing methylphenidate (MPH) treatment could correspond to a reduced use of other treatments options. This study therefore aims to providing insights into the actual practice of paediatricians as well as perceived challenges during the diagnosis and treatment.